Showing 1 – 5 of 5
Relevance | Newest | Oldest |
  • JAMA Oncology Brief Report
    April 25, 2024

    Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

    Giacomo听Montagna,听MD, MPH; Mary M.听Mrdutt,听MD, MS; Susie X.听Sun,听MD; Callie听Hlavin,听MD, MPH; Emilia J.听Diego,听MD; Stephanie M.听Wong,听MD, MPH; Andrea V.听Barrio,听MD; Astrid Botty听van den Bruele,听MD; Neslihan听Cabioglu,听MD, PhD; Varadan听Sevilimedu,听MBBS, DrPH; Laura H.听Rosenberger,听MD, MS; E. Shelley听Hwang,听MD, MPH; Abigail听Ingham,听MBchB; B盲rbel听Papassotiropoulos,听MD; Bich Doan听Nguyen-Str盲uli,听MD; Christian听Kurzeder,听MD; Danilo D铆az听Aybar,听MD; Denise听Vorburger,听MD; Dieter Michael听Matlac,听MD; Edvin听Ostapenko,听MD; Fabian听Riedel,听MD; Florian听Fitzal,听MD; Francesco听Meani,听MD; Franziska听Fick,听MD; Jacqueline听Sagasser,听MD; J枚rg听Heil,听MD, PhD; Hasan听Karanl谋k,听MD; Konstantin J.听Dedes,听MD; Laszlo听Romics,听MD, PhD; Maggie听Banys-Paluchowski,听MD, PhD; Mahmut听Muslumanoglu,听MD; Maria Del Rosario Cueva听Perez,听MD; Marcelo Ch谩vez听D铆az,听MD; Martin听Heidinger,听MD; Mathias K.听Fehr,听MD; Mattea听Reinisch,听MD; Mustafa听Tukenmez,听MD; Nadia听Maggi,听MD; Nicola听Rocco,听MD, PhD; Nina听Ditsch,听MD, PhD; Oreste Davide听Gentilini,听MD; Regis R.听Paulinelli,听MD, PhD; Sebasti谩n Sol茅听Zarhi,听MD; Sherko听Kuemmel,听MD, PhD; Simona听Bruzas,听MD; Simona听di Lascio,听MD; Tamara K.听Parissenti,听MD; Tanya L.听Hoskin,听MS; Uwe听G眉th,听MD; Valentina听Ovalle,听MD; Christoph听Tausch,听MD; Henry M.听Kuerer,听MD, PhD; Abigail S.听Caudle,听MD; Jean-Francois听Boileau,听MD, MSc; Judy C.听Boughey,听MD; Thorsten听K眉hn,听MD, PhD; Monica听Morrow,听MD; Walter P.听Weber,听MD
    Abstract Full Text
    online first
    JAMA Oncol. 2024; 10.1001/jamaoncol.2024.0578

    This cohort study examines oncological outcomes after sentinel lymph node biopsy with dual-tracer mapping or targeted axillary dissection.

  • JAMA Surgery Original Investigation
    March 27, 2024

    Quality of Life After Axillary Lymph Node Dissection Among Racial and Ethnic Minority Women

    Danielle R.听Heller,听MD, MHS; Bayley听Axelrod,听BS, MHA; Varadan听Sevilimedu,听MBBS, PhD; Monica听Morrow,听MD; Babak J.听Mehrara,听MD; Andrea V.听Barrio,听MD
    Abstract Full Text
    online first
    JAMA Surg. 2024; 10.1001/jamasurg.2024.0118

    This cohort study examines the association between race and ethnicity and long-term quality of life after unilateral axillary lymph node dissection in women with breast cancer.

  • JAMA Oncology Brief Report
    June 9, 2022

    Risk Factors and Racial and Ethnic Disparities in Patients With Breast Cancer鈥揜elated Lymphedema

    Giacomo听Montagna,听MD, MPH; Jennifer听Zhang,听MD; Varadan听Sevilimedu,听MBSS, DrPH; Jillian听Charyn,听BS; Kelly听Abbate,听BS; Ethan A.听Gomez,听BS; Babak听Mehrara,听MD; Monica听Morrow,听MD; Andrea V.听Barrio,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2022; 8(8):1195-1200. 10.1001/jamaoncol.2022.1628

    This cohort study evaluate rates and risk factors associated with breast cancer鈥搑elated lymphedema in patients treated with axillary lymph node dissection.

  • JAMA Oncology Brief Report
    October 7, 2021

    Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy鈥擜 Rare Event

    Andrea V.听Barrio,听MD; Giacomo听Montagna,听MD, MPH; Anita听Mamtani,听MD; Varadan听Sevilimedu,听MBBS, DrPH; Marcia听Edelweiss,听MD; Deborah听Capko,听MD; Hiram S.听Cody听III,听MD; Mahmoud听El-Tamer,听MD; Mary L.听Gemignani,听MPH, MD; Alexandra听Heerdt,听MD; Laurie听Kirstein,听MD; Tracy-Ann听Moo,听MD; Melissa听Pilewskie,听MD; George听Plitas,听MD; Virgilio听Sacchini,听MD; Lisa听Sclafani,听MD; Audree听Tadros,听MD; Kimberly J.听Van Zee,听MS, MD; Monica听Morrow,听MD
    Abstract Full Text
    free access
    JAMA Oncol. 2021; 7(12):1851-1855. 10.1001/jamaoncol.2021.4394

    This cohort study examines nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy.

  • 榴莲视频 Network Open Original Investigation Oncology
    January 15, 2021

    Accuracy of Magnetic Resonance Imaging鈥揋uided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial

    Elizabeth J.听Sutton,听MD; Lior Z.听Braunstein,听MD; Mahmoud B.听El-Tamer,听MD; Edi听Brogi,听MD; Mary听Hughes,听MD; Yolanda听Bryce,听MD; Jill S.听Gluskin,听MD; Simon听Powell,听MD, PhD; Alyssa听Woosley,听BS; Audree听Tadros,听MD; Varadan听Sevilimedu,听MBBS, DrPH; Danny F.听Martinez,听MS; Larowin听Toni,听MS; Olga听Smelianskaia,听MHA; C. Gregory听Nyman,听AS; Pedram听Razavi,听MD; Larry听Norton,听MD; Maggie M.听Fung,听MEng; James D.听Sedorovich,听BS; Virgilio听Sacchini,听MD; Elizabeth A.听Morris,听MD
    Abstract Full Text
    open access
    榴莲视频 Netw Open. 2021; 4(1):e2034045. 10.1001/jamanetworkopen.2020.34045

    This nonrandomized controlled trial uses data from a single tertiary care center in the US to investigate the accuracy of magnetic resonance imaging (MRI)鈥揼uided biopsy compared with surgical resection for assessing pathologic complete response after neoadjuvant chemotherapy in patients with breast cancer.